Spectra Science (OTC BB: SCIE) Interview with Jim Hitchin, CEO

This interview has expired.
Click here to find stocks, with exciting stories, and management committed to maximizing shareholder value.

Special deals for our readers
Are you qualified for the Visa Black Card?
The World’s Most Prestigious and Versatile Credit Card. Apply Now!

Be a more profitable investor:
What’s Jim Cramer trading in his personal portfolio? Click here

Get an Equifax 3-in-1 Credit Report Now!

Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing.
Find out why TradeKing.com was ranked #1 Discount Broker by SmartMoney Magazine two years running! (August 2006 & 2007).

Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition!

LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount.

Get FICO Score Watch Now!

Free Quicken Online automatically categorizes your expenses.

Click here to get access to powerful investing tools only available at Investor’s Business Daily.

Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here

Spectra Science
Jim Hitchin, CEO

SpectraScience, Inc. has developed a minimally invasive technology known as WavSTAT Optical Biopsy System (WavSTAT System), which optically scans tissue in real time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. SpectraScience has received approval from the United States Food and Drug Administration (FDA) to market the WavSTAT System. The Company has also developed an additional application for the detection of pre-cancerous and cancerous tissue in the esophagus, as well as has expanded its product offerings to cervical cancer and pre-cancer detection through the acquisition of Luma Imaging Corporation (LUMA). LUMA has developed and received approval from the FDA for an optical, non-invasive diagnostic imaging system to detect cervical cancer precursors.

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.